GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year EV/Core EBITDA History
[Consolidated]
Mar2025 | Mar2024 | |
---|---|---|
EV/Core EBITDA(x) | 26.16 | 21.03 |
What is the latest EV/Core EBITDA ratio of GUFIC BIOSCIENCES ?
Year | EV/Core EBITDA |
---|---|
Mar2025 | 26.16 |
Mar2024 | 21.03 |
How is EV/Core EBITDA of GUFIC BIOSCIENCES Trending?
Years | EV/Core EBITDA | % Change | |
---|---|---|---|
Mar2025 | 26.16 | 24.39 | |
Mar2024 | 21.03 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,527.0 Cr | -4% | -0.6% | -13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,872.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,706.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹127,449.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,125.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,827.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -4% |
-0.6% |
-13.1% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses